췌장 아밀라아제 시약 키트 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 검체 유형별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Pancreatic Amylase Reagent Kits Market size was valued at USD 5.76 Billion in 2024 and is poised to grow from USD 6.09 Billion in 2025 to USD 9.49 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global pancreatic amylase reagent kits market caters to laboratories by providing essential kits for quantifying amylase activity in pancreatic secretions, serving as a key diagnostic marker for pancreatitis and various metabolic disorders. The market has developed due to increased demand for precise measurement in disease monitoring, rooted in the enzyme's critical function in carbohydrate digestion. Expanding hospital networks and a rising prevalence of gastrointestinal diseases have fueled revenue, while regulatory support for precision diagnostics encourages the adoption of high-quality, standardized kits. AI-driven automation is revolutionizing workflows, enhancing efficiency, and reducing error rates. As laboratories increasingly adopt smart instrumentation, there is a significant rise in demand for innovative kits that integrate seamlessly with AI systems, driving growth and fostering competition within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pancreatic Amylase Reagent Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pancreatic Amylase Reagent Kits Market Segments Analysis

Global pancreatic amylase reagent kits market is segmented by product type, sample type, end user, distribution channel and region. Based on product type, the market is segmented into Colorimetric Reagent Kits and Enzymatic Reagent Kits. Based on sample type, the market is segmented into Blood/Serum, Urine and Other Biological Samples. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Academic Laboratories. Based on distribution channel, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pancreatic Amylase Reagent Kits Market

One key market driver for the global pancreatic amylase reagent kits market is the rising prevalence of pancreatic disorders and gastrointestinal diseases, which necessitate efficient diagnostic tools for early detection and management. As healthcare systems globally emphasize preventive care and the importance of accurate diagnostics, the demand for reliable testing kits that measure pancreatic enzyme levels, particularly amylase, is increasing. Additionally, advancements in laboratory technologies and an increase in research activities focused on metabolic disorders are further propelling the market, enabling healthcare providers to better assess patients' health conditions effectively and enhance their therapeutic outcomes.

Restraints in the Global Pancreatic Amylase Reagent Kits Market

One significant market restraint for the global pancreatic amylase reagent kits market is the stringent regulatory environment surrounding the approval and commercialization of diagnostic kits. Regulatory bodies impose rigorous standards for safety, efficacy, and quality, which can lead to delays in product launch and increased costs for manufacturers. Additionally, the complexity of validation processes and the necessity for clinical trials may limit the entry of new players into the market. This regulatory burden can hinder innovation and the expansion of product offerings, ultimately slowing market growth and impacting the availability of advanced diagnostic solutions for pancreatic disorders.

Market Trends of the Global Pancreatic Amylase Reagent Kits Market

The Global Pancreatic Amylase Reagent Kits market is witnessing a surge in demand fueled by the shift towards personalized diagnostics. As healthcare moves towards tailored therapeutic strategies, laboratories are increasingly adopting precise enzymatic assays, with pancreatic amylase kits playing a crucial role in individualized disease monitoring. Clinicians are in search of reliable and reproducible measurements that complement their customized treatment plans, driving manufacturers to innovate and adapt kit formulations for various sample types and streamlined workflows. This trend is fostering collaborations and partnerships in the industry, resulting in improved assay sensitivity and simplified sample handling, thereby broadening clinical applications and widespread market adoption.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pancreatic Amylase Reagent Kits Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Colorimetric Reagent Kits
• Enzymatic Reagent Kits

Global Pancreatic Amylase Reagent Kits Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood/Serum
• Urine
• Other Biological Samples

Global Pancreatic Amylase Reagent Kits Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Academic Laboratories

Global Pancreatic Amylase Reagent Kits Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global Pancreatic Amylase Reagent Kits Market Size & CAGR (2026-2033)

• North America (Product Type, Sample Type, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Sample Type, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sample Type, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sample Type, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sample Type, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSys Diagnostic Systems GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analyticon Biotechnologies GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Mannheim GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho-Clinical Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agappe Diagnostics Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linear Chemicals S.L.U.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Gesellschaft fur Biochemica und Diagnostica mbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosystems S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations